North Life Pharma takes a significant step in its regional expansion in Latin America by establishing a new subsidiary in Panama.
The company aims to register medications locally and make a positive impact on Panamanian society, further solidifying its presence in Latin America alongside other markets such as the Dominican Republic, Ecuador, Guyana, Peru, Bolivia, and Paraguay.
Panama is an important market for North Life Pharma
The decision to open a new subsidiary in the country is supported by several reasons. Firstly, Panama has experienced steady economic growth in recent years, leading to an increased demand for healthcare services and medications. The Panamanian population is increasingly concerned about their well-being and seeks accessible and high-quality options to maintain and improve their health.
Additionally, Panama serves as a significant logistics and trade center, enabling efficient pharmaceutical product supply. Its strategic geographic location, robust infrastructure, and the presence of North Life Pharma subsidiaries in neighboring countries facilitate swift and effective distribution throughout the region.
North Life Pharma in Panama
The new subsidiary in Panama will handle local medication registration, ensuring compliance with the country’s health requirements and regulations. This will enable North Life Pharma to offer its pharmaceutical products directly to Panamanian consumers, both in the private and public markets, providing high-quality pharmaceutical solutions at affordable prices.
For North Life Pharma, this expansion represents a commitment to improving the health of Panamanians and increasing their access to high-quality medications. With the opening of this new subsidiary, North Life Pharma now has a commercial presence in over 10 countries worldwide, bringing them closer to their corporate vision: ensuring that every person on Earth has access to high-quality medications.
